𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Purification and characterization of recombinant human erythropoietin from milk of transgenic pigs

✍ Scribed by Eun Gyo Lee; Seung Hui Lee; Kyung Mi Park; Jung Eun Baek; Sun Hee Yeon; Jin-Ki Park; Won-Kyong Chang; Joon-Ki Jung; Bong Hyun Chung

Publisher
Wiley (John Wiley & Sons)
Year
2009
Tongue
English
Weight
198 KB
Volume
84
Category
Article
ISSN
0268-2575

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND: Human erythropoietin (hEPO), a hydrophobic acidic glycoprotein responsible for the regulation of red blood cell production in mammals, is used for the treatment of anemia. In general, the purification of transgenic animal‐derived therapeutic proteins is not easy due to their low titer concentrations and abundant contaminant proteins. For the first time, here the purification and characterization of rhEPO from the milk of transgenic pigs are described.

RESULTS: The rhEPO was purified by heparin chromatography, reverse‐phase chromatography, and gel filtration chromatography, resulting in a 16.5% yield and > 98% purity. The rhEPO purified from the milk of transgenic pigs contained less acidic isoforms and was underglycosylated in contrast to CHO‐derived rhEPO. Cell proliferation of the F‐36/EPO‐dependent cell line was proportional to the dose of transgenic pig‐derived rhEPO.

CONCLUSION: Transgenic pig‐derived rhEPO with high purity was achieved after three‐step chromatography following two‐step precipitation. The transgenic pig‐derived rhEPO was demonstrated to have comparable potency with CHO‐derived rhEPO. Transgenic pig‐derived rhEPO may not be therapeutically feasible because of different glycosylation, and thus further studies are required to elucidate the effect of this aberrant glycosylation on the biological activity and stability in vivo. Copyright © 2008 Society of Chemical Industry

📜 SIMILAR VOLUMES

Facile purification and characterization
Facile purification and characterization of recombinant human antithrombin III from transgenic goat milk
✍ Yingjun Kong; Guifeng Zhang; Jian Luo; Yongdong Liu; Xiunan Li; Guanghui Ma; Yal 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 154 KB

## Abstract **BACKGROUND:** Antithrombin III (AT III) is a serine protease inhibitor that inhibits thrombin and the activated forms of factors X, VII, IX, XI and XII. Transgenic expression of therapeutic proteins in animal systems has gradually matured from laboratory scale to industrial practice,

Purification of an acidic recombinant pr
Purification of an acidic recombinant protein from transgenic tobacco
✍ Chris Holler; Chenming Zhang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

## Abstract Tobacco has proven to be a promising alternative for the production of recombinant therapeutic proteins and offers numerous advantages over other plants as a host system. However, the recovery and purification steps needed to obtain a protein at high recovery and purity have not been we

Purification of human lysozyme from milk
Purification of human lysozyme from milk and pancreatic juice
✍ Chi-Sun Wang; Hans-Ulrich Kloer 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 343 KB

Human milk lysozyme was purified by heparin-Sepharose affinity chromatography and Sepharose 4B gel-permeation chromatography. This procedure was also found applicable to the purification of human pancreatic juice lysozyme. Double-diffusion analyses indicated that human milk lysozyme was immunochemic

Purification of monoclonal antibodies de
Purification of monoclonal antibodies derived from transgenic goat milk by ultrafiltration
✍ Gautam Lal Baruah; Arpan Nayak; Eric Winkelman; Georges Belfort 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

With the goal of recovering heterologous immunoglobulin (IgG), which comprises 10-15% of the total proteins, from transgenic goat milk at 80% yield and 80% purity, we have developed and tested a two-step membrane isolation and purification process. In the first step, reported earlier by Baruah and B

Purification and characterization of hep
Purification and characterization of heparan sulfate from human primary osteoblasts
✍ Sadasivam Murali; Kerry J. Manton; Vinalia Tjong; Xiaodi Su; Larisa M. Haupt; Si 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

## Abstract Heparan sulfate (HS) is a linear, highly variable, highly sulfated glycosaminoglycan sugar whose biological activity largely depends on internal sulfated domains that mediate specific binding to an extensive range of proteins. In this study we employed anion exchange chromatography, mol